Cita APA

Contreras Mostazo, M. G., Kurrle, N., Casado, M., Fuhrmann, D., Alshamleh, I., Häupl, B., . . . Cascante i Serratosa, M. (2020). Metabolic plasticity is an essential requirement of acquired tyrosine kinase inhibitor resistance in Chronic myeloid leukemia.

Citación estilo Chicago

Contreras Mostazo, Miriam Guadalupe, et al. Metabolic Plasticity Is an Essential Requirement of Acquired Tyrosine Kinase Inhibitor Resistance in Chronic Myeloid Leukemia. 2020.

Cita MLA

Contreras Mostazo, Miriam Guadalupe, et al. Metabolic Plasticity Is an Essential Requirement of Acquired Tyrosine Kinase Inhibitor Resistance in Chronic Myeloid Leukemia. 2020.